166 related articles for article (PubMed ID: 22205846)
1. Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia.
Yang YJ; Yun GW; Song IC; Baek SW; Lee KS; Ryu HW; Lee MW; Lee HJ; Yun HJ; Kim S; Jo DY
Korean J Intern Med; 2011 Dec; 26(4):449-54. PubMed ID: 22205846
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.
Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B
Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Olivieri M; Zaccari G; Gandolfo GM; Galli M
Blood; 1994 Dec; 84(12):4203-8. PubMed ID: 7994034
[TBL] [Abstract][Full Text] [Related]
4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
Diz-Küçükkaya R; Hacihanefioğlu A; Yenerel M; Turgut M; Keskin H; Nalçaci M; Inanç M
Blood; 2001 Sep; 98(6):1760-4. PubMed ID: 11535509
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
Deeb A; Hamdoun S; Dababo K
Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
10. Lupus anticoagulant in immune thrombocytopenic purpura.
Dash S; Marwaha RK; Mohanty S
Indian J Pediatr; 2004 Jun; 71(6):505-7. PubMed ID: 15226559
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
Dayama A; Dass J; Mahapatra M; Saxena R
Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
[TBL] [Abstract][Full Text] [Related]
13. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome].
Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D
Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953
[TBL] [Abstract][Full Text] [Related]
16. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073
[TBL] [Abstract][Full Text] [Related]
17. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
20. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
